Hosseini-Sarvari
69
(2H, m), 3.54 (2H, s), 2.76–3.01 (3H, m). 13C NMR (CDCl3)
δ: 46.5, 54.2, 54.3, 122.7, 135.0, 148.6, 169.1. MS m/z: 200
[M+]. Anal. calcd. for C9H13ClN2O: C, 53.87; H, 6.53;
found: C, 53.66; H, 6.22.
2-(3-Bromophenylamino)cyclohexanol (3j)
Oily liquid. 1H NMR (CDCl3, ppm) δ: 6.93–6.99 (1H, m),
6.75–6.79 (2H, m), 6.53–6.58 (1H, m), 4.15 (2H, br s, NH,
OH), 3.42 (1H, m), 3.10 (1H, m), 2.05 (2H, m), 1.64–1.73
(2H, m), 1.01–1.31 (4H, m). 13C NMR (CDCl3) δ: 24.4,
24.6, 31.6, 33.1, 56.9, 73.9, 115.7, 117.8, 120.4, 129.8,
148.4. MS m/z: 270 [M+]. Anal. calcd. for C12H16BrNO: C,
53.35; H, 5.97; found: C, 53.01; H, 5.67.
2-(Pyridin-2-ylmethylamino)cyclohexanol (3d)
1
Solid; mp 87 °C (lit. 87–88 °C) (2d). H NMR (CDCl3,
ppm) δ: 8.55 (1H, d, J = 4.8), 7.76 (1H, t, J = 5.8), 7.40
(1H, d, J = 2.9), 7.26 (1H, m), 5.20 (2H, br s, –NH, –OH),
4.34 (1H, d, J = 14.5), 4.10 (1H, d, J = 14.5), 3.62 (1H, m),
2.57 (1H, m), 2.01–2.08 (2H, m), 1.67–1.74 (2H, m), 1.18–
1.43 (4H, m). 13C NMR (CDCl3) δ: 24.0, 24.6, 28.8, 33.7,
50.0, 63.3, 72.0, 122.9, 137.1, 149.2, 156.0. MS m/z: 206
[M+]. Anal. calcd. for C12H18N2O: C, 69.87; H, 8.80; found:
C, 69.76; H, 8.66.
2-(4-Bromophenylamino)cyclohexanol (3k)
1
Solid; mp 67 °C. H NMR (CDCl3, ppm) δ: 7.11 (2H, m),
6.45 (2H, m), 3.45 (2H, br s, NH, OH), 3.18–3.25 (1H, m),
2.93–2.99 (1H, m), 1.94 (2H, m), 1.58–1.67 (2H, m), 1.09–
1.25 (4H, m). 13C NMR (CDCl3) δ: 24.4, 24.8, 31.4, 33.4,
59.9, 74.3, 115.7, 116.7, 131.8, 147.0. MS m/z: 269 [M+].
Anal. calcd. for C12H16BrNO: C, 53.35; H, 5.97; found: C,
53.04; H, 5.86.
2-(Phenylamino)cyclohexanol (3e)
1
Solid; mp 58 °C (lit. 58–59 °C) (3c). H NMR (CDCl3,
ppm) δ: 7.13 (2H, t, J = 7.5), 6.65–6.89 (3H, m), 3.45 (2H,
br s, NH, OH), 3.30–3.39 (1H, m), 3.10–3.14 (1H, m), 2.05–
2.10 (2H, m), 1.66–1.76 (2H, m), 1.05–1.35 (4H, m). 13C
NMR (CDCl3) δ: 23.9, 24.2, 31.3, 33.2, 60.3, 74.2, 115.2,
121.9, 129.3, 147.2. MS m/z: 191 [M+]. Anal. calcd. for
C12H17NO: C, 75.35; H, 8.96; Found: C, 75.00; H, 8.56.
2-(3-Hydroxphenylamino)cyclohexanol (3l)
Oily liquid. H NMR (CDCl3, ppm) δ: 7.06 (1H, s), 6.18–
6.27 (3H, m), 4.68 (2H, br s, NH, OH), 3.28 (1H, m), 3.03
(1H, m), 1.99–2.02 (2H, m), 1.61 (2H, m), 1.18–1.26
(4H, m). MS m/z: 206 [M+]. Anal. calcd. for C12H18NO2: C,
69.87; H, 8.79; found: C, 69.60; H, 8.70.
1
2-(p-Toluidino)cyclohexanol (3f)
1-(4-(2-Hydroxycyclohexylamino)phenyl-ethenone (3m)
Solid; mp 79 °C. H NMR (CDCl3, ppm) δ: 7.76 (2H, d,
1
Oily liquid. H NMR (CDCl3, ppm) δ: 6.78 (2H, d, J =
1
2.27), 6.48 (2H, d, J = 2.50), 3.09–3.14 (1H, m), 3.98 (2H,
br s, NH, OH), 2.87–2.93 (1H, m), 3.89 (3H, s), 1.89
(2H, m), 1.56 (2H, m), 1.06–1.18 (4H, m). 13C NMR
(CDCl3) δ: 20.4, 24.5, 25.0, 31.5, 33.1, 60.5, 74.3, 115.3,
127.5, 129.3, 145.5. MS m/z: 205 [M+]. Anal. calcd. for
C13H19NO: C, 76.06; H, 9.33; found: C, 75.98; H, 9.02.
J = 2.07), 6.56 (2H, d, J = 3.10), 4.30 (2H, br s, NH, OH),
3.43 (1H, m), 3.25 (1H, m), 2.48 (3H, s), 2.12 (2H, m),
1.69–1.79 (2H, m), 1.18–1.34 (4H, m). 13C NMR (CDCl3) δ:
23.9, 24.2, 24.6, 31.4, 33.5, 58.9, 74.2, 112.1, 113.6, 130.6,
130.8, 152.3, 196.6. MS m/z: 233 [M+]. Anal. calcd. for
C14H19NO2: C, 72.07; H, 8.21; found: C, 71.89; H, 7.98.
2-(m-Toluidino)cyclohexanol (3g)
1
4-(2-Hydroxycyclohexylamino)benzoic acid (3n)
Solid; mp 167 °C. H NMR (CDCl3, ppm) δ: 7.85 (2H, d,
Oily liquid. H NMR (CDCl3, ppm) δ: 7.02 (1H, s), 6.39–
1
6.60 (3H, m), 3.46 (2H, br s, NH, OH), 3.23 (1H, m), 3.03
(1H, m), 2.21 (3H, s), 2.00 (2H, m), 1.61–1.69 (2H, m),
1.17–1.35(4H, m). 13C NMR (CDCl3) δ: 21.5, 23.7, 25.0,
31.0, 33.4, 59.9, 75.6, 111.5, 115.6, 118.5, 128.7, 139.0,
148.0. MS m/z: 205 [M+]. Anal. calcd. for C13H19NO: C,
76.06; H, 9.33; found: C, 76.00; H, 9.30.
J = 2.32), 6.62 (2H, d, J = 2.12), 4.94 (2H, br s, NH, OH),
3.23–3.43 (2H, m), 2.10 (2H, m), 1.69 (2H, m), 1.02–1.47
(4H, m). 13C NMR (CDCl3) δ: 24.2, 24.4, 30.3, 32.9, 74.2,
113.7, 118.3, 132.2, 151.5, 171.1. MS m/z: 235 [M+]. Anal.
calcd. for C13H17NO3: C, 66.36; H, 7.28; found: C, 66.02; H,
6.98.
2-(4-Methoxyphenylamino)cyclohexanol (3h)
1
2-(4-Nitrophenylamino)cyclohexanol (3o)
Solid; m.p. 53 °C. H NMR (CDCl3, ppm) δ: 7.01 (2H, d,
Solid; mp 143 °C. 1H NMR (CDCl3, ppm) δ: 7.21
(2H, m), 6.64 (2H, m), 3.54 (2H, br s, NH, OH), 3.28–3.35
(1H, m), 3.00–3.12 (1H, m), 2.02 (2H, m), 1.68–1.77
(2H, m), 1.10–1.35 (4H, m). 13C NMR (CDCl3) δ: 24.8,
24.3, 32.4, 33.8, 60.15, 75.3, 115.9, 116.1, 131.6, 147.9. MS
m/z: 236 [M+]. Anal. calcd. for C12H16N2O3: C, 61.00; H,
6.83; found: C, 61.04; H, 6.86.
J = 2.27), 6.84 (2H, d, J = 2.50), 3.29–3.21 (1H, m), 4.01
(2H, br s, NH, OH), 2.87–2.93 (1H, m), 3.91 (3H, s), 2.18
(2H, m), 1.86 (2H, m), 1.36–1.48 (4H, m). 13C NMR
(CDCl3) δ: 21.4, 25.5, 25.8, 32.5, 34.1, 61.5, 75.7, 115.8,
127.1, 129.9, 145.1. MS m/z: 221 [M+]. Anal. calcd. for
C13H19NO2: C, 70.56; H,8.65; found: C, 70.32; H, 8.62.
2-(2-Bromophenylamino)cyclohexanol (3i)
Oily liquid. 1H NMR (CDCl3, ppm) δ: 7.40–7.46 (1H, m),
7.16–7.18 (1H, m), 6.74–6.85 (1H, m), 6.56–6.60 (1H, m)
3.20 (2H, br s, NH, OH), 4.35 (1H, m), 3.38 (1H, m), 2.04–
2.10 (2H, m), 1.67–1.74 (2H, m), 1.13–1.43 (4H, m). 13C
NMR (CDCl3) δ: 24.0, 24.4, 31.5, 32.7, 59.7, 74.1, 112.9,
118.3, 128.3, 132.5, 144.9. MS m/z: 270 [M+]. Anal. calcd.
for C12H16BrNO: C, 53.35; H, 5.97; found: C, 53.01; H,
5.67.
2-(3-Nitrophenylamino)cyclohexanol (3p)
Solid; mp 157 °C. H NMR (CDCl3, ppm) δ: 7.48–7.54
1
(2H, m), 7.27 (1H, t, J = 8.04), 6.95 (1H, d, J = 5.04), 3.41
(2H, br s, NH, OH), 3.25 (1H, m), 3.20 (1H, m), 2.14
(2H, m), 1.73–1.82 (2H, m), 1.13–1.42 (4H, m). 13C NMR
(CDCl3) δ: 24.1, 24.7, 31.4, 33.5, 59.7, 74.5, 107.5, 112.5,
119.7, 129.8, 148.8. MS m/z: 236 [M+]. Anal. calcd. for
C12H16N2O3: C, 61.00; H, 6.83; found: C, 60.97; H, 6.561.
© 2007 NRC Canada